Health
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study. – DocWire News
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study. PLoS Med. 2020
This article was originally published hereCirculating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
PLoS Med. 2020 Oct;17(10):e1003363
Authors: Zivanovic Bujak A, Weng CF, Silva MJ, Yeung M, Lo L, Ftouni S, Litchfield C, Ko YA, Kuykhoven K, Van Geelen C, Chandrashekar S, Dawson MA, Loi S, Wong SQ, Dawson SJ
AbstractBACKGROUND: Metastatic breast cancer (mBC) is a heterogenous disease with increasing availability of targeted the…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News20 hours agoMan dies after stabbing in inner-city unit
-
Noosa News23 hours agoThe Almond Ashes sees Australia and India mix business and cricket